SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
St. Jude Medical, Inc. (STJ) 当前追踪市盈率 (P/E) 为 26.3. 追踪盈利收益率为 3.80%.
本页证实的标准:
- VALUE (60/100, 通过) — 综合估值评分超过60/100的通过门槛。
- 追踪盈利收益率 3.80% — 与债券收益率（约4.3%）大致持平，风险回报适中。
SharesGrow 综合评分： 63/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
60/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — STJ
估值倍数
P/E (TTM)26.3
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率4.18
EV/EBITDA0.0
每股数据
EPS (TTM)$3.07
每股账面价值$0.00
每股营收$19.35
每股自由现金流$0.00
收益率与内在价值
盈利收益率3.80%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2006 |
$1.47 |
$913.51M |
$548.25M |
60% |
| 2007 |
$1.59 |
$1.04B |
$559.04M |
53.7% |
| 2008 |
$1.10 |
$1.17B |
$384.33M |
32.8% |
| 2009 |
$2.26 |
$1.25B |
$777.23M |
62% |
| 2010 |
$2.75 |
$5.16B |
$907.44M |
17.6% |
| 2011 |
$2.52 |
$5.61B |
$825.79M |
14.7% |
| 2012 |
$2.39 |
$5.5B |
$752M |
13.7% |
| 2013 |
$2.49 |
$5.5B |
$723M |
13.1% |
| 2014 |
$3.46 |
$5.62B |
$1B |
17.8% |
| 2015 |
$3.07 |
$5.54B |
$880M |
15.9% |
